Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart rehab boosts strength and mood in elderly with muscle loss

NCT ID NCT07197528

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a 12-week precision exercise program using a smart rehabilitation system in 42 elderly residents of long-term care facilities who had sarcopenia (age-related muscle loss). Participants exercised 3 days per week, 2 sessions per day, with personalized routines. The goal was to see if the program improved muscle strength, joint movement, thinking skills, daily activities, quality of life, and mood. Results are not yet reported, but the approach aims to ease symptoms and improve well-being without curing the underlying condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

42 people

The number who actually took part.

Started

Feb 2025

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults aged 65 years or older residing in long-term care facilities and diagnosed with sarcopenia, defined as: * Handgrip strength: \<28 kg for males or \<18 kg for females, or * Calf circumference (10 cm below the knee): \<34 cm for males or \<33 cm for females. 2. Able to stand with assistive devices (e.g., walker), transfer from bed to chair using a wheelchair, or ambulate independently. 3. Clear consciousness, able to communicate, and able to provide informed consent. 4. Willing to participate and comply with the exercise intervention. Exclusion Criteria: 1. Impaired consciousness. 2. Unsuitable for wearing the device due to any leg-related medical condition. 3. Unable to perform aerobic or resistance training due to neurological or musculoskeletal disorders. 4. History of head injury resulting in cognitive impairments such as memory or attention deficits. 5. Assessed by a rehabilitation specialist as having absolute or relative contraindications to exercise training, such as: * Severe myocardial ischemia * Myocardial infarction within the past 6 months * Unstable angina * Uncontrolled arrhythmias causing symptoms or hemodynamic instability * Severe aortic valve stenosis 6. Deemed unsuitable to participate in the study by a rehabilitation specialist due to conditions such as end-stage renal disease requiring dialysis, terminal cancer, or ongoing chemotherapy/radiation therapy. 7. Diagnosed with depression or experienced major life events in the past six months. 8. Fracture, sports injury of the limbs, stroke, dementia, or other major illness within the past six months. 9. Individuals with infectious disease risks.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Long-term care are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Banqiao Veterans Home of Veterans Affairs Council, R.O.C.

    New Taipei City, Banqiao Dist, 220250, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.